Pharmaceutical Technology

MARCH 24, 2023

Until 2010, no regulatory approval pathway for biosimilars existed in the US and the first biosimilar was only approved in the US in 2015. Many pharma companies hold extensive patent protections and have ongoing patent litigation cases. Further, there remains scepticism on the efficacy and safety of biosimilars.

Competition 59

Competition Marketing FDA Physicians 59

Clarify Health

JULY 13, 2020

Pharmaceutical commercialization On average, 23 approvals for new drugs were granted each year between 2000 and 2010. Bhash cautioned, “if we do not start planning for their launches today, the investment pharma is making will not pay off.” Pharma real-world data The use of real-world data emerged as an area that is ripe for progress.

Pharmaceutical 52

Pharmaceutical Pharma Patients Marketing 52

Pharma Marketing Network

OCTOBER 11, 2021

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. This can help Pharma deliver results and respond to the customer needs faster.

Healthcare 59

Healthcare Healthcare Marketing Insurance 59

Pharma Marketing Network

OCTOBER 11, 2021

Quickly adapting to a new reality due to the COVID-19 pandemic was a theme throughout this year’s Pharma Marketing Network Innovation Summit 2021, linking all three panels: “ Telehealth: Past. Success in pharma marketing with telehealth. This can help Pharma deliver results and respond to the customer needs faster.

Healthcare 52

Healthcare Healthcare Marketing Insurance 52

Clarivate

MAY 24, 2022

In May 2010, the Chinese Medical Association (CMA) reached an expert consensus that defined rare diseases as those with a prevalence of less than 1 in 500,000, or with a morbidity rate of less than 1 in 10,000, among newborns. [2] Multinational pharmas seek entry for their products. Establishing a definition of rare disease.

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

PM360

JUNE 11, 2022

Qualitative and quantitative research help pharma brand teams understand physician and patient attitudes, behaviors, and perspectives. For example, consider a pharma brand team trying to market its newest triple inhaler therapy for the treatment of COPD against its top competitor. Seize the Initiative.

Marketing 52

Marketing Competition Pharma Manufacturing 52

Pharmaceutical Technology

OCTOBER 5, 2008

But the recent acquisition by Japanese pharmaceutical provider Shionogi of US-based rival Sciele Pharma, worth $1,276m, is just the latest in a spree of big and bold outbound deals. However, BMI forecasts that the market share for these low-cost products in Japan will double by 2010, adding almost $5bn in value to the sector.”

Government 52

Government Marketing Pharmaceutical Physicians 52